Cargando…
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
The antigenicity of cells is demarcated by the peptides bound by their Human Leucocyte Antigen (HLA) molecules. Through this antigen presentation, T cell specificity response is controlled. As a fraction of the expressed mutated peptides is presented on the HLA, these neo-epitopes could be immunogen...
Autores principales: | Kalaora, Shelly, Barnea, Eilon, Merhavi-Shoham, Efrat, Qutob, Nouar, Teer, Jamie K., Shimony, Nilly, Schachter, Jacob, Rosenberg, Steven A., Besser, Michal J., Admon, Arie, Samuels, Yardena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868674/ https://www.ncbi.nlm.nih.gov/pubmed/26819371 http://dx.doi.org/10.18632/oncotarget.6960 |
Ejemplares similares
-
Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides
por: Besser, Hanan, et al.
Publicado: (2019) -
A highly recurrent RPS27 5'UTR mutation in melanoma
por: Dutton-Regester, Ken, et al.
Publicado: (2014) -
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017) -
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
por: Kalaora, Shelly, et al.
Publicado: (2020) -
Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse
por: Rijensky, Nataly Mancette, et al.
Publicado: (2020)